Cross-Talk Between T Cells and Hematopoietic Stem Cells During Adoptive Cellular Therapy for Malignant Glioma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-17-3061
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Recognition of Glioma Stem Cells by Genetically Modified T Cells Targeting EGFRvIII and Development of Adoptive Cell Therapy for Glioma

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2012English

Editorial: Cross Talk Between Lymph Node Lymphatic Endothelial Cells and T-Cells During Inflammation and Cancer

Frontiers in Immunology
AllergyImmunology
2017English

Virotherapy Against Malignant Glioma Stem Cells

Cancer Letters
Cancer ResearchOncology
2010English

Adoptive Cellular Therapy Using Bone Marrow-Derived T Cells for the Treatment of Childhood Leukemia

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Effective Combination Therapy for Malignant Glioma With TRAIL-Secreting Mesenchymal Stem Cells and Lipoxygenase Inhibitor MK886

Cancer Research
Cancer ResearchOncology
2012English

Cross-Talk Between Antigen Presenting Cells and T Cells Impacts Intestinal Homeostasis, Bacterial Infections, and Tumorigenesis

Frontiers in Immunology
AllergyImmunology
2019English

Limitations of Cross-Talk Between Osteosarcoma and Bone Marrow-Derived Mesenchymal Stem Cells

Journal of Basic and Clinical Health Sciences
2019English

Developing Allogeneic Double Negative T Cells as a Novel Off-The-Shelf Adoptive Cellular Therapy for Cancer

Clinical Cancer Research
Cancer ResearchOncology
2019English

29. Redirected Allogeneic T Cells for Adoptive Cell Therapy of Cancer

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy